Dihexa is a nooptropic (cognitive enhancer) and a small peptide that has been developed by researchers from Washington State University to potently improve certain cognitive function of potential trauma-based brain disorders and neurodegenerative conditions through increased synaptogenesis.
Dihexa has also been called a “neurogenic wonder-drug” and the peptide can be ten million times stronger than BDNF (Brain-derived neurotrophic factor), one of the leading medications for new synapse formation.